METROPOLITAN LIFE INSURANCE CO/NY - ANIKA THERAPEUTICS INC ownership

ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 118 filers reported holding ANIKA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of ANIKA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$15,482
-28.3%
8310.0%0.00%0.0%
Q2 2023$21,589
-9.5%
8310.0%0.00%0.0%
Q1 2023$23,866
-24.4%
831
-22.0%
0.00%0.0%
Q4 2022$31,554
+24.4%
1,0660.0%0.00%0.0%
Q3 2022$25,371
+6.6%
1,0660.0%0.00%0.0%
Q2 2022$23,793
-11.1%
1,0660.0%0.00%0.0%
Q1 2022$26,767
-83.9%
1,066
-77.1%
0.00%
-50.0%
Q4 2021$166,538
-15.8%
4,6480.0%0.00%
-33.3%
Q3 2021$197,819
-1.7%
4,6480.0%0.00%0.0%
Q2 2021$201,212
+6.1%
4,6480.0%0.00%0.0%
Q1 2021$189,592
-9.9%
4,6480.0%0.00%0.0%
Q4 2020$210,368
+27.9%
4,6480.0%0.00%0.0%
Q3 2020$164,493
-6.2%
4,6480.0%0.00%0.0%
Q2 2020$175,369
+18.0%
4,648
-9.6%
0.00%0.0%
Q1 2020$148,626
-44.2%
5,1410.0%0.00%
-25.0%
Q4 2019$266,561
-5.5%
5,1410.0%0.00%
-20.0%
Q3 2019$282,189
+35.1%
5,1410.0%0.01%
+25.0%
Q2 2019$208,827
+34.3%
5,1410.0%0.00%
+33.3%
Q1 2019$155,464
-10.0%
5,1410.0%0.00%0.0%
Q4 2018$172,789
-20.3%
5,1410.0%0.00%
-25.0%
Q3 2018$216,847
-99.9%
5,1410.0%0.00%
+33.3%
Q2 2018$164,512,000
-35.6%
5,1410.0%0.00%
-25.0%
Q1 2018$255,611,000
+92178.3%
5,1410.0%0.00%0.0%
Q4 2017$277,000
-54.1%
5,141
-50.6%
0.00%0.0%
Q3 2017$604,000
+17.5%
10,4170.0%0.00%0.0%
Q2 2017$514,000
+13.5%
10,4170.0%0.00%
+33.3%
Q1 2017$453,000
-11.2%
10,4170.0%0.00%
-25.0%
Q4 2016$510,000
+2.4%
10,4170.0%0.00%0.0%
Q3 2016$498,000
-10.9%
10,4170.0%0.00%0.0%
Q2 2016$559,000
+16.7%
10,417
-2.7%
0.00%0.0%
Q1 2016$479,000
+17.4%
10,7040.0%0.00%
+33.3%
Q4 2015$408,000
+24.0%
10,704
+3.5%
0.00%
+50.0%
Q3 2015$329,000
-7.3%
10,346
-3.7%
0.00%0.0%
Q2 2015$355,000
-22.5%
10,742
-3.4%
0.00%
-33.3%
Q1 2015$458,000
+1.1%
11,1210.0%0.00%0.0%
Q4 2014$453,000
+11.0%
11,1210.0%0.00%0.0%
Q3 2014$408,000
-20.8%
11,1210.0%0.00%
-25.0%
Q2 2014$515,000
+12.7%
11,1210.0%0.00%
+33.3%
Q1 2014$457,000
+7.8%
11,1210.0%0.00%0.0%
Q4 2013$424,000
+59.4%
11,1210.0%0.00%
+50.0%
Q3 2013$266,000
+40.7%
11,1210.0%0.00%0.0%
Q2 2013$189,00011,1210.00%
Other shareholders
ANIKA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Euclidean Technologies Management, LLC 44,875$2,031,0002.14%
Parian Global Management LP 102,705$4,648,0001.16%
CAPITAL MANAGEMENT CORP /VA 93,035$4,211,0001.15%
Avidity Partners Management LP 731,000$33,085,0001.07%
Sio Capital Management, LLC 65,382$2,959,0000.61%
DIKER MANAGEMENT LLC 21,835$988,0000.50%
Archon Capital Management LLC 48,925$2,214,0000.38%
Caption Management, LLC 362,800$16,420,0000.37%
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 1,546,260$69,984,0000.20%
Boston Trust Walden Corp 378,167$17,116,0000.18%
View complete list of ANIKA THERAPEUTICS INC shareholders